ERRONEOUS RESULTS FROM PHASE-FRAME REPRESENTATION OF STAR-DELTA TRANSFORMER

被引:0
|
作者
ROY, L [1 ]
RAO, BH [1 ]
机构
[1] INDIAN INST TECHNOL,KHARAGPUR 721302,W BENGAL,INDIA
来源
关键词
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
引用
收藏
页码:1321 / 1321
页数:1
相关论文
共 50 条
  • [21] Characteristics Analysis of Three-Phase Diode Rectifier Isolated by Transformer with Delta-Star Windings on Rectangular-Voltage-Fed Distribution System
    Kito, Minoru
    Takeshita, Takaharu
    Nishida, Yasuyuki
    PROCEEDINGS OF 14TH INTERNATIONAL POWER ELECTRONICS AND MOTION CONTROL CONFERENCE (EPE-PEMC 2010), 2010,
  • [22] A Three-Phase Isolated Secondary-Resonant Single-Active-Bridge DC-DC Converter with a Delta-Star Connected Transformer
    Nishio, Atsushi
    Budo, Kohei
    Van Tuan, Mai
    Takeshita, Takaharu
    2022 24TH EUROPEAN CONFERENCE ON POWER ELECTRONICS AND APPLICATIONS (EPE'22 ECCE EUROPE), 2022,
  • [23] Practical Evaluation of Rectangular-Voltage-Fed Distribution System Loaded by Choke-Input Type Three-Phase Diode Rectifier Through Delta/Star Winding Isolation Transformer
    Nishida, Yasuyuki
    Ohyama, Hiromichi
    Takeshita, Takaharu
    PROCEEDINGS OF THE 2011-14TH EUROPEAN CONFERENCE ON POWER ELECTRONICS AND APPLICATIONS (EPE 2011), 2011,
  • [24] USE OF ROMOSOZUMAB IN THOSE WHO EXPERIENCED AN ON-STUDY FRACTURE: RESULTS FROM THE RANDOMISED FRAME AND ARCH PHASE 3 TRIALS
    Lane, J.
    Cosman, F.
    Langdahl, B.
    Stone, M.
    Oates, M.
    Timoshanko, J.
    Wang, Z.
    Libanati, C.
    Kurth, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S40 - S41
  • [25] Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565)
    Nalamachu, Srinivas
    Pergolizzi, Joseph
    Kaye, Randall
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 3059 - 3069
  • [26] Sensor-Augmented Pump Therapy for A1c Reduction (STAR 3) Study: Results from the 6-Month Continuation Phase
    Bergenstal, Richard M.
    Tamborlane, William V.
    Ahmann, Andrew
    Buse, John B.
    Dailey, George
    Davis, Stephen N.
    Joyce, Carol
    Peoples, Tim
    Perkins, Bruce A.
    Welsh, John B.
    Willi, Steven M.
    Wood, Michael A.
    DIABETES, 2011, 60 : A112 - A113
  • [27] Efficacy and Safety of Bulevirtide Monotherapy for Chronic Hepatitis Delta in Patients With and Without Cirrhosis: Results From the Week 96 Interim Analysis of a Phase 3 Randomized Study
    Aleman, Soo
    Wedemeyer, Heiner
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Da, Ben
    Flaherty, John F.
    Buensuceso, Paul
    Osinusi, Anu
    Lau, Audrey H.
    Christian-Cox, Florence
    Tseng, Steve
    zur Wiesch, Julian Schulze
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1384 - S1385
  • [28] Low immunogenicity potential of follitropin delta, a recombinant FSH preparation produced from a human cell line: Results from phase 3 trials (ESTHER-1 and ESTHER-2)
    Rasmussen, B. Buur
    Mannaerts, B.
    Klein, B. M.
    Helmgaard, L.
    Arce, J. C.
    HUMAN REPRODUCTION, 2016, 31 : 376 - 376
  • [29] EFFICACY AND SAFETY AT 96 WEEKS OF BULEVIRTIDE 2 MG OR 10 MG MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: RESULTS FROM AN INTERIM ANALYSIS OF A PHASE 3 RANDOMIZED STUDY
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia R.
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana V.
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Flaherty, John F.
    Osinusi, Anu
    Lau, Audrey H.
    Wiesch, Julian Schulze zur
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    GASTROENTEROLOGY, 2024, 166 (05) : S1600 - S1600
  • [30] EFFICACY AND SAFETY AT 96 WEEKS OF BULEVIRTIDE 2 MG OR 10 MG MONOTHERAPY FOR CHRONIC HEPATITIS DELTA: RESULTS FROM AN INTERIM ANALYSIS OF A PHASE 3 RANDOMIZED STUDY
    Wedemeyer, Heiner
    Aleman, Soo
    Brunetto, Maurizia
    Blank, Antje
    Andreone, Pietro
    Bogomolov, Pavel
    Chulanov, Vladimir
    Mamonova, Nina
    Geyvandova, Natalia
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Manuilov, Dmitry
    Mercier, Renee-Claude
    An, Qi
    Flaherty, John
    Osinusi, Anu
    Lau, Audrey
    zur Wiesch, Julian Schulze
    Cornberg, Markus
    Zeuzem, Stefan
    Lampertico, Pietro
    GUT, 2023, 72 (SUPPL_3) : A103 - A104